Hong Kong is a place where its residents have previously enjoyed economic prosperity and civil liberties. That is coming to an end. Through the proposed “national security” law, the CCP (China’s ruling party) has pretty much announced that it has given up on trying to win over Hong Kongers and will now proceed to act against them without their consent. The CCP has indicated that its weird obsession with control will trump sensible economic decisions.
The Hong Kongers who choose to stay will almost certainly make the CCP burn with them. The CCP will never control the Hong Kong people and turn them into obedient mainlanders who sing the Chinese national anthem instead of the Hong Kong anthem. At the same time, the Hong Kong people will suffer a terrible price at the hands of the CCP much like the Uyghur Muslims, Tibetians, Falun Gong, etc.
The loss of freedom is in many ways worse than COVID-19. Tanya Chan, a pro-democracy lawmaker, has described the day of the national security laws being introduced as the “saddest day in Hong Kong[‘s] history”.
TIKR is a startup whose goal is to bring institutional-quality investment research tools to a broader audience. TIKR provides:
- Standardized financial data (from S&P Capital IQ) so that you can quickly put together financial models.
- High-quality conference call transcripts with better coverage and fewer typos than many other transcript providers.
While TIKR is in beta, you can sign up for a free account.
COVID-19 is going to be awful. Society will have plenty of assets (e.g. cruise ships) and unemployed people that will be fairly unproductive in the next few years. But, while I’m extremely scared of what COVID-19 will do to most stocks, I think that now is the time to invest in stocks (*that won’t get killed by COVID-19). What worked in the past will likely continue to work in the future:
- Buying high quality businesses…
- …at reasonable prices…
- …that aren’t in shrinking industries.
COVID-19 has dramatically changed #2 and #3. Many industries that were previously stable or booming may see a wave of bankruptcies. But that’s ok. I don’t have to own those stocks. Nobody is holding a gun to my head forcing me to own airlines, movie theatres, department stores, etc. There is still a small universe of stocks with low COVID-19 risk that I will concentrate my portfolio in.
Here are the excesses that I see in the lending markets:
- When investors put money into securitizations, they don’t pay attention to the underwriting quality of the loans that they own a piece of. They allow charlatans to unload low-quality loans into securitizations. Investors are ultimately buying into a pile of loans with inflated values. Unfortunately, yield-chasing investors gravitate towards assets that they don’t understand. This may be a desirable feature for the yield chasers- they will look smarter if others also don’t understand what the yield chasers own.
- Certain instruments such as Credit Risk Transfers (CRTs) and the lower tranches of CMBS have a significant chance of being completely wiped out. While the riskiest tranches of CRTs and CMBS have seen their prices drop 30%+, it doesn’t seem like investors are sufficiently scared about the senior CRT tranches in a COVID-19 environment.
- The system of yield-chasing mortgage REITs financing themselves almost entirely with short-term debt does not work. There are currently liquidity issues because lenders do not want to continue providing short-term debt (via repos / repurchase agreements) and the lenders also don’t want to sell the collateral. A key reason why problems exist is because the banks accepted highly leveraged investments as collateral.
I don’t think that the mortgage REIT stocks are very interesting because (A) none of them are good longs and (B) it’s not a good use of time to research them as shorts.
It has been difficult for me to accept that I should be buying stocks with high P/E ratios, high P/B ratios, and mediocre management teams. Quality rarely comes cheap and without warts. But, I’ve been trying to move away from deep value investing dogma because I want to figure out what actually works. As part of that, I’ve been keeping a model portfolio of 30-35 large cap stocks since October 2017 that you can view in real-time here. It has outperformed the S&P 500 by ~5% annually since October 2017 (!). This is a surprising amount of outperformance for large cap stocks (e.g. large cap mutual funds would be incredibly happy with 2% outperformance).
While it is possible that I am confusing luck with good stock picking, I have to live with imperfect information. I would prefer the feedback from a 30+ stock portfolio than the feedback from a focused portfolio with <10 stocks. Going forward, you should expect me to be heavily biased towards quality companies.
If you read up on coronaviruses that affect livestock, you will quickly discover that some viruses remain a problem despite vaccination. Chickens continue to die from IBV (Infectious Bronchitis Virus) despite being vaccinated. While vaccines improve the chickens’ health overall, they are not good enough to fully solve the problem. If a SARS-Cov-2 vaccine would be similar to our vaccines for IBV, then we will have to deal with the limitations of vaccines.
The simplest way to think about the current COVID-19 situation is that there will be a range of outcomes, with the worst outcome being a prolonged economic depression where a vaccine doesn’t exist (or that people die despite being vaccinated). You can make your portfolio robust against COVID-19 risk by ensuring that you own “safe” stocks that will do fine in a world where social distancing is the new normal.
I apologize for my recent blog posts because they’re uncomfortable. I want to believe that the world will be ok. But the further I go down this rabbit hole, the more I realize that health authorities spread misinformation and ignore scientific evidence. The most disturbing element of the current situation is that many Western scientific authorities promote bad science so that companies have a chance of profiting from the situation via drug treatments, the experimental use of invasive ventilators, and vaccines. They stand in the way of science saving us.